Company intelligence / Profile preview

NeoGeneStar

Somerset, New Jersey, United Statesneogenestar.com ↗

Ownership: Private
Development stage: Commercial

Overview

NeoGeneStar has developed patented solid-phase reagents and innovative magnetic devices enabling high-yield, artifact-free extraction of cell-free DNA/RNA from plasma, urine, saliva, and other fluids. Their kits support applications in liquid biopsy for early cancer detection and non-invasive prenatal testing. The company’s technologies offer over 95% retention rates of DNA fragments as small as ~20 bases up to >2kb[1][2][3]. Customers include leading US/international cancer centers and genetic testing labs[1].

Modalities: DeviceReagent/Kit (for nucleic acid purification)Magnetic separation technology (enabling liquid biopsy and cfDNA/cfRNA analysis)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on NeoGeneStar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeoGeneStar.

Explore the full profile